Tianjin, China – July 28, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and pioneer of invasive fungal disease diagnostic field since 199...
Era Biology at ECCMID 2023, Denmark
Era Biology, a leader and pioneer of invasive fungal disease (IFD) diagnostics field, has exhibited at the European Congress of Clinical Microbiology and Infecti...
YY/T 1729-2020 “Fungus (1-3)-β-D-Glucan Test” formulated by Era Biology was approved by NMPA on July 9, 2020 and officially released. The standard will be formally implemented on June 1...
Meet Genobio at ISHAM 2022
The 21st Congress of the International Society for Human and Animal Mycology (ISHAM) will be held in New Delhi, India on 20-24 September 2022.
ISHAM is a worldwide o...
A new starting point for the industry standard
Following YY/T 1729-2020 “Fungi (1-3)-β-D glucan determination kit”, YY/T 1793-2021 “Bacterial Endotoxin Determination Kit” fo...
Meet Era Biology at Medlab Middle East 2023
The Medlab Middle East 2023 exhibition will be held in Dubai World Trade Centre, The United Arab Emirates on 6-9 February 2023.
As the largest healthcare...